Stock Market News1 month ImmunoPrecise Antibodies Ltd. (IPA) Reports Q2 Loss, Misses Revenue Estimates Zacks
ImmunoPrecise Antibodies (IPA) delivered earnings and revenue surprises of -40% and 12.21%, respectively, for the quarter ended October 2024. Do the numbers hold clues to what lies ahead for the stock?
X